Skip to main content
Top
Published in: World Journal of Surgery 9/2020

01-09-2020 | Portal Vein Thrombosis | Original Scientific Report

Massage of the Hepatoduodenal Ligament Recovers Portal Vein Flow Immediately After the Pringle Maneuver in Hepatectomy

Authors: Junji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Tetsuya Shimizu, Tomohiro Kanda, Hideyuki Takata, Ryota Kondo, Yohei Kaneya, Yuto Aoki, Hiroshi Yoshida

Published in: World Journal of Surgery | Issue 9/2020

Login to get access

Abstract

Background

The Pringle maneuver is often used in liver surgery to minimize bleeding during liver transection. Many authors have demonstrated that intermittent use of the Pringle maneuver is safe and effective when performed appropriately. However, some studies have reported that the Pringle maneuver is a significant risk factor for portal vein thrombosis. In this study, we evaluated the effectiveness of portal vein flow after the Pringle maneuver and the impact that massaging the hepatoduodenal ligament after the Pringle maneuver has on portal vein flow.

Materials and Methods

Patients treated with the Pringle maneuver for hepatectomies performed to treat hepatic disease at our hospital between August 2014 and March 2019 were included in the study (N = 101). We divided these patients into two groups, a massage group and nonmassage group. We measured portal vein blood flow with ultrasonography before and after clamping of the hepatoduodenal ligament. We also evaluated laboratory data after the hepatectomy.

Results

Portal vein flow was significantly lower after the Pringle maneuver than before clamping of the hepatoduodenal ligament. The portal vein flow after the Pringle maneuver was improved following massage of the hepatoduodenal ligament. After hepatectomy, serum prothrombin time was significantly higher and serum C-reactive protein was significantly lower in the massage group than in the nonmassage group.

Conclusion

Massaging the hepatoduodenal ligament after the Pringle maneuver is recommended in order to quickly recover portal vein flow during hepatectomy and to improve coagulability.
Literature
1.
go back to reference Yoshida H, Taniai N, Yoshioka M et al (2019) Current status of laparoscopic hepatectomy. J Nippon Med Sch 86:201–206CrossRef Yoshida H, Taniai N, Yoshioka M et al (2019) Current status of laparoscopic hepatectomy. J Nippon Med Sch 86:201–206CrossRef
2.
go back to reference Yoshioka M, Taniai N, Kawano Y et al (2019) Effectiveness of laparoscopic repeat hepatectomy for recurrent liver cancer. J Nippon Med Sch 86:222–229CrossRef Yoshioka M, Taniai N, Kawano Y et al (2019) Effectiveness of laparoscopic repeat hepatectomy for recurrent liver cancer. J Nippon Med Sch 86:222–229CrossRef
3.
go back to reference Pringle JHV (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48:541–549CrossRef Pringle JHV (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48:541–549CrossRef
4.
go back to reference Makuuchi M, Mori T, Gunven P et al (1987) Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 164:155–158PubMed Makuuchi M, Mori T, Gunven P et al (1987) Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 164:155–158PubMed
5.
go back to reference Quan D, Wall WJ (1996) The safety of continuous hepatic inflow occlusion during major liver resection. Liver Transpl Surg 2:99–104CrossRef Quan D, Wall WJ (1996) The safety of continuous hepatic inflow occlusion during major liver resection. Liver Transpl Surg 2:99–104CrossRef
6.
go back to reference Jaeschke H (2003) Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284:G15–G26CrossRef Jaeschke H (2003) Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284:G15–G26CrossRef
7.
go back to reference Glanemann M, Vollmar B, Nussler AK et al (2003) Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 38:59–66CrossRef Glanemann M, Vollmar B, Nussler AK et al (2003) Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 38:59–66CrossRef
8.
go back to reference Serracino-Inglott F, Habib NA, Mathie RT (2001) Hepatic ischemia-reperfusion injury. Am J Surg 181:160–166CrossRef Serracino-Inglott F, Habib NA, Mathie RT (2001) Hepatic ischemia-reperfusion injury. Am J Surg 181:160–166CrossRef
9.
go back to reference Kupiec-Weglinski JW, Busuttil RW (2005) Ischemia and reperfusion injury in liver transplantation. Transpl Proc 37:1653–1656CrossRef Kupiec-Weglinski JW, Busuttil RW (2005) Ischemia and reperfusion injury in liver transplantation. Transpl Proc 37:1653–1656CrossRef
10.
go back to reference Zhang ZY, Dong KS, Zhang EL et al (2018) Acute portal vein thrombosis after hepatectomy in a patient with hepatolithiasis: a case report and review of the literature. Med (Baltimore) 97:e11174CrossRef Zhang ZY, Dong KS, Zhang EL et al (2018) Acute portal vein thrombosis after hepatectomy in a patient with hepatolithiasis: a case report and review of the literature. Med (Baltimore) 97:e11174CrossRef
12.
go back to reference Rouxel P, Beloeil H (2019) Enhanced recovery after hepatectomy: a systematic review Anaesth Crit Care. Pain Med 38:29–34 Rouxel P, Beloeil H (2019) Enhanced recovery after hepatectomy: a systematic review Anaesth Crit Care. Pain Med 38:29–34
13.
go back to reference Ueda J, Yoshida H, Mamada Y et al (2018) Evaluation of the impact of preoperative values of hyaluronic acid and type IV collagen on the outcome of patients with hepatocellular carcinoma after hepatectomy. J Nippon Med Sch 85:221–227CrossRef Ueda J, Yoshida H, Mamada Y et al (2018) Evaluation of the impact of preoperative values of hyaluronic acid and type IV collagen on the outcome of patients with hepatocellular carcinoma after hepatectomy. J Nippon Med Sch 85:221–227CrossRef
14.
go back to reference Qi X, Han G, Fan D (2014) Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 11:435–446CrossRef Qi X, Han G, Fan D (2014) Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 11:435–446CrossRef
15.
go back to reference Rodriguez-Castro KI, Porte RJ, Nadal E et al (2012) Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 94:1145–1153CrossRef Rodriguez-Castro KI, Porte RJ, Nadal E et al (2012) Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 94:1145–1153CrossRef
16.
go back to reference Smoot RL, Christein JD, Farnell MB (2006) Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg 10:1371–1375CrossRef Smoot RL, Christein JD, Farnell MB (2006) Durability of portal venous reconstruction following resection during pancreaticoduodenectomy. J Gastrointest Surg 10:1371–1375CrossRef
17.
go back to reference Ushitora Y, Tashiro H, Takahashi S et al (2011) Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 28:9–14CrossRef Ushitora Y, Tashiro H, Takahashi S et al (2011) Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 28:9–14CrossRef
18.
go back to reference Ravaioli M, Zanello M, Grazi GL et al (2011) Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 253:378–384CrossRef Ravaioli M, Zanello M, Grazi GL et al (2011) Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 253:378–384CrossRef
19.
go back to reference Yerdel MA, Gunson B, Mirza D et al (2000) Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69:1873–1881CrossRef Yerdel MA, Gunson B, Mirza D et al (2000) Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69:1873–1881CrossRef
20.
go back to reference Kuboki S, Shimizu H, Ohtsuka M et al (2015) Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience. Am J Surg 210:878–885CrossRef Kuboki S, Shimizu H, Ohtsuka M et al (2015) Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience. Am J Surg 210:878–885CrossRef
21.
go back to reference Then EO, Are VS, Lopez-Luciano M et al (2019) Elevated international normalized ratio: a risk factor for portal vein thrombosis in cirrhotic patients. Gastroenterol Res 12:135–140CrossRef Then EO, Are VS, Lopez-Luciano M et al (2019) Elevated international normalized ratio: a risk factor for portal vein thrombosis in cirrhotic patients. Gastroenterol Res 12:135–140CrossRef
22.
go back to reference Levy JH, Szlam F, Wolberg AS et al (2014) Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med 34:453–477CrossRef Levy JH, Szlam F, Wolberg AS et al (2014) Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clin Lab Med 34:453–477CrossRef
23.
go back to reference Triplett DA (2000) Coagulation and bleeding disorders: review and update. Clin Chem 46:1260–1269CrossRef Triplett DA (2000) Coagulation and bleeding disorders: review and update. Clin Chem 46:1260–1269CrossRef
24.
go back to reference Barcellona D, Fenu L, Marongiu F (2017) Point-of-care testing INR: an overview. Clin Chem Lab Med 55:800–805CrossRef Barcellona D, Fenu L, Marongiu F (2017) Point-of-care testing INR: an overview. Clin Chem Lab Med 55:800–805CrossRef
25.
go back to reference Zhao J, Liu J, Pang X et al (2013) Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-kappaB signal pathway in hepatocytes. Cell Physiol Biochem 32:569–580CrossRef Zhao J, Liu J, Pang X et al (2013) Angiotensin II induces C-reactive protein expression via AT1-ROS-MAPK-NF-kappaB signal pathway in hepatocytes. Cell Physiol Biochem 32:569–580CrossRef
26.
go back to reference Fasing KA, Nissan BJ, Greiner JJ et al (2014) Influence of elevated levels of C-reactive protein on circulating endothelial progenitor cell function. Clin Transl Sci 7:137–140CrossRef Fasing KA, Nissan BJ, Greiner JJ et al (2014) Influence of elevated levels of C-reactive protein on circulating endothelial progenitor cell function. Clin Transl Sci 7:137–140CrossRef
27.
go back to reference Suh W, Kim KL, Choi JH et al (2004) C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 321:65–71CrossRef Suh W, Kim KL, Choi JH et al (2004) C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun 321:65–71CrossRef
28.
go back to reference Jun JH, Choi JH, Bae SH et al (2016) Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation. Clin Mol Hepatol 22:372–381CrossRef Jun JH, Choi JH, Bae SH et al (2016) Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation. Clin Mol Hepatol 22:372–381CrossRef
29.
go back to reference Kolahdoozan M, Behdad A, Hosseinpour M et al (2015) Evaluation of the safe ischemic time of clamping during intermittent Pringles maneuver in rabbits. Arch Trauma Res 4:e30244CrossRef Kolahdoozan M, Behdad A, Hosseinpour M et al (2015) Evaluation of the safe ischemic time of clamping during intermittent Pringles maneuver in rabbits. Arch Trauma Res 4:e30244CrossRef
30.
go back to reference Kang KJ, Jang JH, Lim TJ et al (2004) Optimal cycle of intermittent portal triad clamping during liver resection in the murine liver. Liver Transpl 10:794–801CrossRef Kang KJ, Jang JH, Lim TJ et al (2004) Optimal cycle of intermittent portal triad clamping during liver resection in the murine liver. Liver Transpl 10:794–801CrossRef
Metadata
Title
Massage of the Hepatoduodenal Ligament Recovers Portal Vein Flow Immediately After the Pringle Maneuver in Hepatectomy
Authors
Junji Ueda
Yasuhiro Mamada
Nobuhiko Taniai
Masato Yoshioka
Atsushi Hirakata
Youichi Kawano
Tetsuya Shimizu
Tomohiro Kanda
Hideyuki Takata
Ryota Kondo
Yohei Kaneya
Yuto Aoki
Hiroshi Yoshida
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 9/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05570-7

Other articles of this Issue 9/2020

World Journal of Surgery 9/2020 Go to the issue